Implementing Methods to Improve Perioperative Hemostasis in the Surgical and Trauma Settings

AORN Journal

Volumn 92, Issue 5, 2010, Pages

  Neveleff, Deborah J ^a   Kraiss, Larry W ^a   Schulman, Christine S ^a  

^a NONE

Author keywords

Bovine collagen; Bovine thrombin; Fibrin sealant; Hemostasis; Immune mediated coagulopathy; Oxidized regenerated cellulose; Polysaccharide spheres; Pooled human thrombin; Porcine gelatin; Recombinant thrombin

Indexed keywords

ARTICLE; BLEEDING; BLOOD CLOTTING; HEMOSTASIS; HUMAN; INJURY; NURSING; PATHOPHYSIOLOGY; PERIOPERATIVE NURSING;

BLOOD COAGULATION; BLOOD LOSS, SURGICAL; HEMOSTASIS; HUMANS; PERIOPERATIVE NURSING; WOUNDS AND INJURIES;

EID: 78049251446     PISSN: 00012092     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aorn.2010.08.006     Document Type: Article

References (29)

1. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT study: anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004, 32(1):39-52.
2. Boucher B.A., Hannon T.J. Blood management: a primer for clinicians. Pharmacotherapy 2007, 27(10):1394-1411.
3. Owings J.T., Utter G.H., Gosselin R.C. Bleeding and transfusion. ACS Surgery: Principles & Practice 2007, 61-76. WebMD Professional Publishing, New York, NY. 6th ed. W.W. Souba, M.P. Fink, G.J. Jurkovich (Eds.).
4. The clotting process (hemostasis). King Faisal Specialist Hospital and Research Centre Accessed August 8, 2010. http://rc.kfshrc.edu.sa/rcf/E_Library/S-TAFT/TheClottingProcess(Hemostasis).pdf.
5. Davie E.W., Kulman J.D. An overview of the structure and function of thrombin. Semin Thromb Hemost 2006, 32(Suppl 1):3-15.
6. Sarfati M.R., DiLorenzo D.J., Kraiss L.W., Galt S.W. Severe coagulopathy following intraoperative use of topical thrombin. Ann Vasc Surg 2004, 18(3):349-351.
7. Escolar G., Díaz-Ricart M., Cases A. Uremic platelet dysfunction: past and present. Curr Hematol Rep 2005, 4(5):359-367.
8. Levy J.H., Dutton R.P., Hemphill J.C., et al. Multidisciplinary approach to the challenge of hemostasis. Anesth Analg 2010, 110(2):354-364.
9. Totonchi A., Eshraghi Y., Beck D., McCrae K., Guyuron B. Von Willebrand disease: screening, diagnosis, and management. Aesthet Surg J 2008, 28(2):189-194.
10. Kasai T., Hirose M., Yaegashi T., Matsukawa T., Takamata A., Tanaka Y. Preoperative risk factors of intraoperative hypothermia in major surgery under general anesthesia. Anesth Analg 2002, 95(5):1381-1383.
11. Rajagopalan S., Mascha E., Na J., Sessler D.I. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology 2008, 108(1):71-77.
12. Reynolds L., Beckmann J., Kurz A. Perioperative complications of hypothermia. Best Pract Res Clin Anaesthesiol 2008, 22(4):645-657.
13. Hendrickson J.E., Hillyer C.D. Noninfectious serious hazards of transfusion. Anesth Analg 2009, 108(3):759-769.
14. Damage control surgery Trauma.org, Accessed August 8, 2010. http://www.trauma.org/archive/resus/DCSmetabolicfailure.html.
15. Spotnitz W.D., Burks S. Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion 2008, 48(7):1502-1516.
16. Chapman W.C., Singla N., Genyk Y., et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg 2007, 205(2):256-265.
17. Clark J.A., Humphries J.E., Crean S., Reynolds M.W. Topical bovine thrombin: a 21-year review of topical bovine thrombin spontaneous case safety reports submitted to FDA's Adverse Event Reporting System. Pharmacoepidemiol Drug Saf 2010, 19(2):107-114.
18. Vaccines, blood & biologics. Approved products. US Food and Drug Administration Accessed August 8, 2010. http://www.fda.gov/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/default.htm.
19. Terrab A., Pawlak D., Spaay P., Hoppensteadt D., Fareed J. Further removal of factor v related antigen from bovine thrombin by utilizing a membrane-filtration step. Clin Appl Thromb Hemost 2008, 14(2):135-140.
20. ® [package insert] 2008, ZymoGenetics Inc, Seattle, WA, Accessed August 12, 2010. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm120557.pdf.
21. ® [package insert] 2007, Ethicon, Inc, Somerville, NJ, Accessed August 12, 2010. http://www.fda.gov/downloads/BiologicsBloodVaccines/BloodBloodProducts/ApprovedProducts/LicensedProductsBLAs/FractionatedPlasmaProducts/ucm074092.pdf.
22. ® [package insert] 2007, King Pharmaceuticals, Inc, Bristol, TN, Accessed August 12, 2010. http://www.kingpharm.com/products/product_document.cfm?brand_name=Thrombin%2DJMI%26product_specific_name=%26document_type_code=PI.
23. Ness P., Creer M., Rodgers G.M., et al. Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety. Patient Saf Surg 2009, 3(1):8.
24. Rodgers G.M., Kraiss L.W. Severe postoperative immune-mediated coagulopathy associated with bovine thrombin exposure. Pharmacotherapy 2010, 30(8):319e-324e. [case report].
25. Safety implications of fractionated blood products. US Food and Drug Administration Accessed August 8, 2010. http://www.fda.gov/NewsEvents/Testimony/ucm114908.htm.
26. Oz M.C., Cosgrove D.M., Badduke B.R., et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg 2000, 69(5):1376-1382.
27. Woodworth B.A., Chandra R.K., LeBenger J.D., Ilie B., Schlosser R.J. A gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery. Am J Otolaryngol 2009, 30(1):49-53.
28. de la Torre R.A., Bachman S.L., Wheeler A.A., Bartow K.N., Scott J.S. Hemostasis and hemostatic agents in minimally invasive surgery. Surgery 2007, 142(4 Suppl):S39-S45.
29. Schwartz M., Madariaga J., Hirose R., et al. Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 2004, 139(11):1148-1154.